Announcement on Obtaining Summary Report of Phase II Clinical Trial for Zhilong Tongluo Tablets

About this update from Hunan Fangsheng Pharmaceutical Co., Ltd. Class A

Announcement on Obtaining Summary Report of Phase II Clinical Trial for Zhilong Tongluo TabletsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hunan Fangsheng Pharmaceutical Co., Ltd. Class A